Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06063629
Other study ID # 030/2565
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 1, 2024
Est. completion date February 2025

Study information

Verified date April 2024
Source Queen Savang Vadhana Memorial Hospital, Thailand
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Surgical site infections (SSI) pose a common challenge in the field of surgery. Current evidence and literature do not provide clear consensus whether the use of subcutaneous drainage will help reduce the incidence of SSI in patients who underwent abdominal surgery, especially in wounds that are categorized as contaminated (class 3) or dirty/infected (class 4). The objective of this clinical study is to compare the rate of surgical site infection in contaminated and dirty/infected surgical wounds among patients whose wounds are inserted with subcutaneous drainage and patients who are not inserted with subcutaneous drainage.


Description:

This study is a randomized, controlled and open study, where participants who undergo abdominal surgery will be randomly allocated into two groups: (i) patients whose wounds are inserted with subcutaneous negative pressure drain and (ii) patients whose wounds are not inserted with subcutaneous negative pressure drain. The participants in this study will know the details about the presence of their drain placement after the operation. If the patient was assigned to the drain group, the drain will be placed for five days or until there are no content observed in the drain. The primary outcome of this study is the occurrence of SSI, which will be tracked up to 30 days post-operation. The patient in both groups will also be evaluated by the surgeons at day 3, 5, 7, 14 and 30 post-operation for signs and complications of SSI. In situation where the patients are discharged prior to the date of evaluation, the patients will be scheduled for evaluation during the follow-up visits. If SSI is detected in the drain group prior to removal, the drain will be removed and the patient will be treated with wet dressing combined with antibiotics. Complications of SSI will also be noted. Patient's data on demographic, medical history, clinical presentation, details of operation, and other laboratory findings will also be collected to investigate for risk factors for development of SSI between each group.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 180
Est. completion date February 2025
Est. primary completion date September 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age equal or over 18 years old - Admitted to Queen Savang Vadhana Memorial Hospital - Receive abdominal surgery and were classified as class 3 or 4 wound Exclusion Criteria: - Patients who undergo operation for ostomy - Patients who do not receive appropriate antibiotics - Patients who undergo operation before full recover of prior operation - Patients who undergo laparoscopic operation - Pregnant women - Patients who had history of prior radiation therapy at abdomen - Patient with immunocompromised status - Patient with chronic skin disease

Study Design


Intervention

Procedure:
Subcutaneous drain
The drain will be inserted into subcutaneous layer of the surgical wound. Redivac drain will be used in this study.
No drain
No drain will be inserted into patients allocated to this group

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Queen Savang Vadhana Memorial Hospital, Thailand

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of Surgical Site Infection (SSI) The rate of SSI will be compared between the drain and no drain group Post operation day 3
Primary Rate of Surgical Site Infection (SSI) The rate of SSI will be compared between the drain and no drain group Post operation day 5
Primary Rate of Surgical Site Infection (SSI) The rate of SSI will be compared between the drain and no drain group Post operation day 7
Primary Rate of Surgical Site Infection (SSI) The rate of SSI will be compared between the drain and no drain group Post operation day 14
Primary Rate of Surgical Site Infection (SSI) The rate of SSI will be compared between the drain and no drain group Post operation day 30
Secondary Length of hospital stay The length of hospital stay will be compared between drain and no drain group Post operation day 3
Secondary Length of hospital stay The length of hospital stay will be compared between drain and no drain group Post operation day 5
Secondary Length of hospital stay The length of hospital stay will be compared between drain and no drain group Post operation day 7
Secondary Length of hospital stay The length of hospital stay will be compared between drain and no drain group Post operation day 14
Secondary Length of hospital stay The length of hospital stay will be compared between drain and no drain group Post operation day 30
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04096885 - The Inselspital Surgical Cohort Study
Terminated NCT03820648 - Wound Protector Dual-ring Alexis® in Pancreaticoduodenectomy N/A
Completed NCT04067843 - Effect of Photodynamic Treatment on Skin Microbiome. Single Center Study N/A
Terminated NCT04042077 - Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections Phase 3
Completed NCT05841576 - Anaesthetic Management Guided by COMET Measurements N/A
Withdrawn NCT05338281 - NPWT for Abdominal Incisions in DIEP Reconstructions: A RCT N/A
Recruiting NCT03042091 - Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery Early Phase 1
Completed NCT01697748 - Prospective Study on Cesarean Wound Outcomes N/A
Terminated NCT01789697 - Text Message Study N/A
Recruiting NCT05966961 - Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery
Recruiting NCT05077592 - Addition of Pre-wound Closure Povidone Iodine Wash Versus Direct Wound Closure Effect on Surgical Site Infections Phase 4
Recruiting NCT05763602 - PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study) Phase 4
Recruiting NCT05502380 - Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery Phase 3
Recruiting NCT03221023 - Intrawound Vancomycin Prophylaxis for Neural Stimulator Phase 2/Phase 3
Completed NCT03257202 - Topical Treatment and Prevalence of P. Acnes Phase 2
Completed NCT06154720 - Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population
Not yet recruiting NCT06465901 - A Stratified, Multi-ARm, muLti-site Randomised Platform Trial Aiming to Reduce the INcidence of Post-operative SSI N/A
Not yet recruiting NCT04820075 - Efficacy of an Intervention to Improve the Preoperative Shower in Scheduled Surgery N/A
Recruiting NCT03561376 - Zinc Oxide Versus Petrolatum Following Skin Surgery Early Phase 1
Not yet recruiting NCT04496180 - Prevena to Prevent Surgical Site Infection After Emergency Abdominal Laparotomy N/A